Scientific Opinion on the substantiation of a health claim related to "low fat and low trans spreadable fat rich in unsaturated and omega-3 fatty acids" and reduction of LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006

被引:6
作者
Agostoni, Carlo [1 ]
Bresson, Jean-Louis [1 ]
Fairweather-Tait, Susan [1 ]
Flynn, Albert [1 ]
Golly, Ines [1 ]
Korhonen, Hannu [1 ]
Lagiou, Pagona [1 ]
Lovik, Martinus [1 ]
Marchelli, Rosangela [1 ]
Martin, Ambroise [1 ]
Moseley, Bevan [1 ]
Neuhauser-Berthold, Monika [1 ]
Przyrembel, Hildegard [1 ]
Salminen, Seppo [1 ]
Sanz, Yolanda [1 ]
Strain, Sean [1 ]
Strobel, Stephan [1 ]
Tetens, Inge [1 ]
Tome, Daniel [1 ]
van Loveren, Hendrik [1 ]
Verhagen, Hans [1 ]
机构
[1] EFSA, Parma, Italy
关键词
Saturated fatty acids; monounsaturated fatty acids; polyunsaturated fatty acids; unsaturated fatty acids; LDL cholesterol; coronary heart disease; health claims;
D O I
10.2903/j.efsa.2011.2168
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following an application from Lactalis B&C submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to "low fat and low trans spreadable fat rich in unsaturated and omega-3 fatty acids" and reduction of LDL-cholesterol concentrations. The food constituents which are responsible for the claimed effect are unsaturated fatty acids (mixtures of cis-MUFA and/or cis-PUFA), which should replace saturated fatty acids (SFAs) and trans fatty acids (TFAs) in the diet in order to obtain the claimed effect. Lowering LDL-cholesterol concentrations is a beneficial physiological effect by reducing the risk of coronary heart disease. There is consensus on the role of trans-MUFA in increasing total and LDL-cholesterol concentrations compared to cis-MUFA or cis-PUFA. Foods containing TFA typically contain high amounts of SFA, which are likely to have similar effects to TFA on a gram-for-gram basis. The Panel concludes that a cause and effect relationship has been established between the consumption of mixtures of dietary SFAs and an increase in blood LDL-cholesterol concentrations, and that replacement of a mixture of SFAs with cis-MUFAs and/or cis-PUFAs in foods or diets on a gram-per-gram basis reduces LDL-cholesterol concentrations. The following wording reflects the scientific evidence: "Consumption of saturated fat increases blood cholesterol concentrations; consumption of mono-and/or polyunsaturated fat in replacement of saturated fat has been shown to lower/reduce blood cholesterol. Blood cholesterol lowering may reduce the risk of (coronary) heart disease". In order to bear the claim, significant amounts of mixed SFAs should be replaced by cis-MUFAs and/or cis-PUFAs in foods or diets on a gram-per-gram basis. The target population is subjects who want to lower their blood cholesterol. (C) European Food Safety Authority, 2011
引用
收藏
页数:13
相关论文
共 15 条
  • [1] Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL-cholesterol concentrations (ID 621, 1190, 1203, 2906, 2910, 3065) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    [J]. EFSA JOURNAL, 2011, 9 (04)
  • [2] Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    [J]. EFSA JOURNAL, 2010, 8 (03)
  • [3] [Anonymous], 2002, WORLD HLTH REPORT 20
  • [4] Diet, lifestyle, and nonstatin trials: Review of time to benefit
    Denke, MA
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (5A) : 3F - 10F
  • [5] EFSA N., 2004, EFSA J, V81, P1, DOI [10.2903/j.efsa.2004.81, DOI 10.2903/J.EFSA.2004.81]
  • [6] Gordon DJ, 2000, CHOLESTEROL-LOWERING THERAPY, P299
  • [7] Institute of Medicine (IOM), 2005, DIET REF INT EN CARB
  • [8] Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels
    Katan, MB
    Grundy, SM
    Jones, P
    Law, M
    Miettinen, T
    Paoletti, R
    [J]. MAYO CLINIC PROCEEDINGS, 2003, 78 (08) : 965 - 978
  • [10] Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
    Mensink, RP
    Zock, PL
    Kester, ADM
    Katan, MB
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (05) : 1146 - 1155